Horizon Technology Finance Corp. 2016 10-K Summary
Business Context and Reporting Period
Company: Horizon Technology Finance Corporation (HRZN)
Reporting Period: Fiscal Year Ended December 31, 2016
Business Model: An externally managed, closed-end, non-diversified Business Development Company (BDC) and Regulated Investment Company (RIC). The Company focuses on "Venture Lending," providing secured debt investments (Senior Term Loans) to development-stage companies in technology, life science, healthcare information/services, and cleantech industries. Returns are generated through interest income and capital appreciation from warrants received alongside debt investments.
Key Financial Metrics
| Metric | 2016 Value | 2015 Value |
|---|---|---|
| Total Investment Income | $32.98 million | $31.11 million |
| Net Investment Income | $17.10 million | $14.00 million |
| Net Realized Loss on Investments | ($7.78 million) | ($1.65 million) |
| Net Unrealized Depreciation | ($14.24 million) | ($0.49 million) |
| Net Decrease in Net Assets from Operations | ($4.91 million) | $11.86 million |
| Total Assets | $239.25 million | $280.90 million |
| Total Borrowings (Net) | $95.60 million | $114.95 million |
| Total Net Assets | $139.19 million | $159.75 million |
| Net Asset Value (NAV) per Share | $12.09 | $13.85 |
| Distributions Declared per Share | $1.335 | $1.380 |
| Portfolio Yield (Dollar-Weighted Annualized) | 14.9% | 14.2% |
Material Changes vs. Prior Period
- Portfolio Contraction: The total portfolio fair value decreased from $250.3 million in 2015 to $194.0 million in 2016. This was driven by significant net unrealized depreciation ($14.2 million) and net realized losses ($7.8 million), partially offset by new debt investments of $59.9 million.
- Asset Quality Deterioration: The number of debt investments rated "1" (high risk of loss) increased from 1 in 2015 to 4 in 2016. These four investments had a cost of $26.2 million but a fair value of only $11.5 million.
- Expense Reduction: Total net expenses decreased by 6.7% to $16.0 million. Notably, the performance-based incentive fee dropped 39.3% to $2.1 million due to the application of the "Incentive Fee Cap and Deferral Mechanism," which deferred $1.7 million in fees due to portfolio losses.
- Debt Repayment: The Company fully repaid its $14.5 million Asset-Backed Notes during 2016. Borrowings under the Key Facility decreased from $68.0 million to $63.0 million.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted that the decline in net assets was primarily due to the resolution of three distressed debt investments and unrealized depreciation on others. The Company maintained its monthly distribution policy, though a portion of distributions may be a return of capital given the net decrease in net assets.
Liquidity and Capital Resources: As of December 31, 2016, the Company held $37.1 million in cash and money market funds. It had $32.0 million of unused commitment capacity under its Key Facility. The Company believes current resources are sufficient for the next 12 months.
Key Risks and Contingencies:
- Credit Risk: Four portfolio companies are on non-accrual status. The Company faces risks related to the illiquidity of private debt investments and the potential for further realized losses if portfolio companies fail to raise additional capital.
- Interest Rate Risk: The Company is exposed to rising interest rates, which could increase borrowing costs faster than investment yields reset, compressing net investment income.
- Regulatory Constraints: As a BDC, the Company must maintain 200% asset coverage to pay distributions or issue additional debt. As a RIC, it must distribute 90% of taxable income to avoid corporate-level taxes.
- Advisor Dependency: The Company relies entirely on its external Advisor for investment decisions and operations.
Investor Verification Checklist
- Non-Accrual Exposure: Verify the specific status and recovery prospects of the four debt investments rated "1" (New Haven Pharmaceuticals, Digital Signal Corporation, ScoreBig, and Xtera Communications).
- Distribution Sustainability: Confirm the source of the $1.335 per share distribution declared for 2016, specifically the portion derived from return of capital versus net investment income.
- Incentive Fee Deferrals: Review the impact of the $1.7 million deferred incentive fee on future expense recognition and net investment income.
- Key Facility Covenants: Ensure continued compliance with the Key Facility covenants, particularly regarding asset coverage and portfolio concentration limits.
- Warrant Valuation: Assess the fair value methodology for the 78 warrant holdings, which represent a significant portion of potential upside but are currently valued at $6.4 million.